GlassScriptPhysician profile
Colman David Sudduth
NPI 1851387310
$31,497.79
in general payments reported to CMS, 2019-2025
61 companies · $5,617 in 2025
The $5,617 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,954 · 2020: $2,091 · 2021: $2,482 · 2022: $9,641 · 2023: $3,747 · 2024: $4,966 · 2025: $5,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $34.00 · Consulting Fee: $18.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,277.60 |
| Education | $34.00 |
| Consulting Fee | $18.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,317.41 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $3,448.41 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $3,010.87 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $1,954.17 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $1,741.99 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Genzyme Corporation | $1,593.54 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,345.34 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Insmed, INC. | $952.30 | 2020-2025 | Arikayce, Brinsupri |
| Mallinckrodt Hospital Products INC. | $927.76 | 2020-2025 | Acthar, Terlivaz |
| Actelion Pharmaceuticals US, INC. | $618.68 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Takeda Pharmaceuticals U.S.A., INC. | $605.45 | 2020-2025 | Cuvitru, Glassia, Hyqvia |
| Amgen INC. | $555.29 | 2022-2025 | Tezspire |
| Inspire Medical Systems, INC. | $457.34 | 2022-2025 | Inspire |
| Sunovion Pharmaceuticals INC. | $456.47 | 2019-2020 | |
| Mylan Specialty L.P. | $406.11 | 2019-2024 | Yupelri |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $391.84 | 2020-2025 | Tyvaso, Tyvaso, Remodulin |
| Ani Pharmaceuticals, INC. | $387.54 | 2023-2024 | Purified Cortrophin Gel |
| Merck Sharp & Dohme LLC | $371.29 | 2019-2025 | Winrevair, Keytruda |
| Harmony Biosciences LLC | $363.67 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $352.51 | 2021-2023 | Ultomiris |
| Jazz Pharmaceuticals INC. | $318.08 | 2019-2025 | Xywav |
| Electromed, INC. | $315.94 | 2019-2025 | Smartvest |
| Csl Behring | $302.35 | 2019-2025 | Hizentra |
| Pulmonx Corporation | $293.30 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Octapharma USA, INC. | $288.51 | 2020-2021 | |
| Philips North America LLC | $282.30 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Novartis Pharmaceuticals Corporation | $275.33 | 2019-2024 | |
| Verona Pharma, INC. | $240.67 | 2025 | Ohtuvayre |
| Pfizer INC. | $227.45 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $213.99 | 2019-2024 | |
| Viatris Specialty LLC | $177.71 | 2025 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $175.01 | 2023-2025 | Lumryz |
| Medtronic, INC. | $174.47 | 2021-2024 | Illumisite |
| Inogen, INC. | $167.36 | 2023-2025 | Inogen |
| Abbvie INC. | $162.87 | 2021-2025 | |
| Baxter Healthcare | $159.68 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Ethicon INC. | $150.04 | 2019-2020 | |
| Axsome Therapeutics, INC. | $142.78 | 2023-2025 | Sunosi |
| La Jolla Pharmaceutical Company | $138.59 | 2022-2025 | Giapreza |
| Abiomed | $118.72 | 2022 | |
| Covidien LP | $108.89 | 2019-2020 | |
| Allergan, INC. | $102.43 | 2019-2020 | |
| Boston Scientific Corporation | $101.25 | 2021-2024 | |
| Genentech USA, INC. | $87.54 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $77.09 | 2022-2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $63.47 | 2019-2024 | Xarelto |
| Shionogi INC | $51.07 | 2024-2025 | Fetroja |
| Vifor Pharma, INC. | $45.17 | 2024 | Veltassa, Zemaira |
| Mallinckrodt Enterprises LLC | $40.63 | 2019 | |
| Alk-Abello, INC | $31.67 | 2025 | Ragwitek, Odactra, Grastek |
| Circassia INC. | $30.38 | 2019-2020 | |
| Olympus America INC. | $20.89 | 2021 | |
| Tempus Ai, INC | $20.78 | 2025 | Xt Cdx |
| Seqirus USA INC | $20.65 | 2025 | Fluad, Flucelvax |
| Vanda Pharmaceuticals INC. | $19.09 | 2020 | |
| Adma Biomanufacturing LLC | $18.46 | 2024 | |
| Paratek Pharmaceuticals, INC. | $17.49 | 2025 | Nuzyra |
| Zoll Respicardia, INC. | $16.05 | 2023 | Remede System |
| Portola Pharmaceuticals, LLC | $15.18 | 2020 | |
| Fisher & Paykel Healthcare INC | $13.69 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $12.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colman Sudduth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.